Clinical guidelines must be free of bias, presenting a balanced view of risks and benefits, in which the preferences of patients, best clinical practice and healthcare policy needs are underpinned by the best available scientific evidence. To achieve these essential attributes, the EAU Guidelines Office has systematically introduced Cochrane review methodology across all 20 Guidelines Panels, ensuring that high quality systematic reviews underpin key recommendations. This process is ongoing and would not be possible without the continued work of Guidelines Office Methods Committee. The Methods Committee, chaired by Prof.Dr. Richard Sylvester, is charged with the development and implementation of methodological standards. Their key aim is to provide a transparent link between guideline recommendations and the scientific evidence on which they are based. They provide methodological support for all EAU Guidelines Panels and comprehensive training in Cochrane systematic review methodology whilst ensuring that all systematic reviews are of the highest methodological quality.
Prof.Dr. N. Lumen, Ghent (BE) (chair)
Dr. I. Omar, Aberdeen (UK) (vice-chair)
Prof.Dr. S. Canfield, Houston (TX, USA)
Dr. S. MacLennan, Aberdeen (UK)
Dr. L. Marconi, Coimbra (PT)
Dr. A.K. Nambiar, Newcastle (UK)
Dr. C. Yuhong Yuan, Hamilton (ON, CN)
Prof. C. Tudur Smith, Liverpool (UK)
Prof.Dr. J. N’Dow, Aberdeen (UK) – ex-officio
The Guidelines Office Rapid Reaction Group (GORRG) aims to provide rapid guidance underpinned by the best knowledge available to support the urological community by providing tools aimed at facilitating decision-making in unprecedented situations.
For each new situation, the group, composed of highly-experienced and respected Board and Guidelines Panel members, produce a protocol and methodology in close collaboration with other relevant EAU offices, the Executive Committee and senior management.
Aim of these revised recommendations is to support the management of urological conditions in exceptional circumstances, whilst minimising the impact and risks for both patients and clinicians, whenever possible.
James N’Dow (Chair GO Board)
Maria Ribal (Vice-chair GO Board and Vice-chair MIBC Guidelines Panel)
Philip Cornford (GO Board and Vice-chair PCa Panel)
Alberto Briganti (GO Board)
Thomas Knoll (GO Board)
Marko Babjuk (Chair NMIBC Panel)
Axel Bex (Vice-chair RCC Panel)
Alberto Breda (Chair Renal Transplantation Panel)
Stavros Gravas (Chair Male LUTS Panel)
Chris Harding (Chair Female LUTS Panel)
Jens Rassweiler (Section Office Chair)
First project: Recommendations on COVID-19
Effective dissemination of the EAU Guidelines, whilst important, must be followed-up by assessment of their impact on clinical practice. In order to achieve this, the EAU Guidelines Office has launched the Impact Assessment of Guidelines Implementation and Education (IMAGINE) group, chaired by Prof.Dr. Alberto Briganti. It is the firm belief of the IMAGINE group that evidence-based medicine should be complemented by evidence based implementation. It is the goal of the group to establish a knowledge translation setting which will allow the gap between evidence and practice to be bridged. Key to this endeavour, in conjunction with effective dissemination and education, is the identification of barriers to knowledge transfer, or more importantly, the identification of the optimum interventions to limit or overcome such barriers; ultimately, making the EAU Guidelines recommendations more relevant and actionable whilst enhancing their influence on patient care.
A. Briganti, Milan (IT) (Chair)
S. Maclennan, Aberdeen (UK)
L. Marconi, Coimbra (PT)
J. N’Dow, Aberdeen (UK) – Ex-officio
Clinical guidelines must be underpinned by the best available scientific evidence. However, gaps do exist either between clinical practice and available research findings or within specific clinical areas where there is both positive and negative data for a specific test or intervention, not allowing for clear conclusions to be drawn. In such cases, formal consensus finding is of the upmost importance. The role of the CONFIDENCE Committee is to ensure that EAU related consensus finding is done in a structured and transparent fashion, based on a standardised protocol thereby, securing involvement of all relevant stakeholders in the process. The CONFIDENCE Committee has developed a phased approach to the selection of topics for consensus finding activities which includes a structured identification of the most relevant stakeholders for the each identified topic. Adoption of this highly systematic and transparent approach should directly impact on the uptake and significance of the Committee’s findings.
A. Bex, Amsterdam (NL) (Chair)
G. Athanasiadis, Aberdeen (UK)
M. Bruins, Nijmegen (NL)
J. N’Dow, Aberdeen (UK) – Ex-officio
Development of Clinical Practice Guidelines, whilst important, must fundamentally be supported by an effective dissemination strategy. To enhance the dissemination of the EAU Guidelines recommendations, the Social Media (SoMe) Committee, chaired by Prof.Dr. Maria Ribal, has been tasked with promoting discussion and triggering feedback from guidelines users via Facebook and Twitter. From its official start in January 2015, the hashtag #eauguidelines has disseminated over 5,000 tweets resulting in upwards of five million impressions and leading to a 40% increase in the number of followers of the EAU Twitter account @uroweb.
M.J. Ribal, Barcelona (ES) (Chair) @
Dr. N. Bhatt, Norwich (UK) @NikitaB0709
I. van Oort, Nijmegen (NL) @
Dr. V. Cucchiara, Milan (IT) @Cucchiara_v
Dr. S. Czarniecki, Warsaw (PL) @DrCzarniecki
Dr. F. Esperto, Bergamo (IT) @fraeserto
Dr. E. Garcia Rojo, Madrid (ES) @rojo_esther
Dr. G. Giannarini, Milan (IT) @GGiannarini
Dr. B. Pradere, Paris (FR) @BenjaminPradere
Dr. J. Teoh, Hong Kong (PRC) @jteoh_hk